These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7078427)

  • 1. Impaired renal mevalonate metabolism in nephrotic syndrome: a stimulus for increased hepatic cholesterogenesis independent of GFR and hypoalbuminemia.
    Golper TA; Swartz SH
    Metabolism; 1982 May; 31(5):471-6. PubMed ID: 7078427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of circulating mevalonate in nephrotic hypercholesterolemia in the rat.
    Golper TA; Feingold KR; Fulford MH; Siperstein MD
    J Lipid Res; 1986 Oct; 27(10):1044-51. PubMed ID: 3794548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid metabolism in daunomycin-induced nephrotic rats (5)].
    Gomikawa S; Inagaki O; Mori H; Fujita Y
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):985-93. PubMed ID: 2263029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic cholesterol metabolism in experimental nephrotic syndrome.
    al-Shurbaji A; Humble E; Rudling M; Lindenthal B; Berglund L
    Lipids; 1998 Feb; 33(2):165-9. PubMed ID: 9507238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal handling of high-density lipoproteins by isolated perfused kidneys.
    Saku K; Reddy GS; Hynd BA; Kashyap ML
    Metabolism; 1984 May; 33(5):432-8. PubMed ID: 6717275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal sodium handling occurs in the isolated perfused kidney of the nephrotic rat.
    Firth JD; Raine AE; Ledingham JG
    Clin Sci (Lond); 1989 Apr; 76(4):387-95. PubMed ID: 2653702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of natriuretic agents, vasoactive agents and of the inhibition of metabolism on sodium handling in the isolated perfused kidney of the nephrotic rat.
    Firth JD; Ledingham JG
    Clin Sci (Lond); 1990 Dec; 79(6):559-74. PubMed ID: 2176943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome.
    Ichikawa I; Rennke HG; Hoyer JR; Badr KF; Schor N; Troy JL; Lechene CP; Brenner BM
    J Clin Invest; 1983 Jan; 71(1):91-103. PubMed ID: 6848563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary clearance and metabolism of mevalonate by the isolataed perfused rat kidney.
    Brunengraber H; Weinstock SB; Story DL; Kopito RR
    J Lipid Res; 1981 Aug; 22(6):916-20. PubMed ID: 7276751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
    Hoyer JR; Mauer SM; Michael AF
    J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats.
    Thabet MA; Challa A; Chan JC; Pandak WM; Heuman DM; Vlahcevic ZR
    Kidney Int; 1993 Oct; 44(4):789-94. PubMed ID: 8258956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the shunt pathway of mevalonate metabolism to the regulation of cholesterol synthesis in rat liver.
    Marinier E; Lincoln BC; Garneau M; David F; Brunengraber H
    J Biol Chem; 1987 Dec; 262(35):16936-40. PubMed ID: 3680279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal sodium retention during volume expansion in experimental nephrotic syndrome.
    Bernard DB; Alexander EA; Couser WG; Levinsky NG
    Kidney Int; 1978 Nov; 14(5):478-85. PubMed ID: 750693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quantitative role of the kidneys in the in vivo metabolism of mevalonate.
    Wiley MH; Howton MM; Siperstein MD
    J Biol Chem; 1977 Jan; 252(2):548-54. PubMed ID: 833143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The shunt pathway of mevalonate metabolism in the isolated perfused rat kidney.
    Kopito RR; Murray DM; Story DL; Brunengraber H
    J Biol Chem; 1984 Jan; 259(1):372-7. PubMed ID: 6706942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative role of different embryonic tissues in mevalonate metabolism by sterol and nonsterol pathways. Relationship with enzyme activities of cholesterogenesis.
    Marco C; González-Pacanowska D; Segovia JL; García-Peregrín E
    Biochim Biophys Acta; 1986 Sep; 878(2):238-42. PubMed ID: 3019412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria.
    Ni Z; Vaziri ND
    Biochim Biophys Acta; 2003 Jul; 1638(2):129-37. PubMed ID: 12853118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys.
    McNamara DJ; Ahrens EH; Parker TS; Morrissey K
    J Clin Invest; 1985 Jul; 76(1):31-9. PubMed ID: 4019781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the proximal tubular sodium/proton exchanger NHE3 in rats with puromycin aminonucleoside (PAN)-induced nephrotic syndrome.
    Besse-Eschmann V; Klisic J; Nief V; Le Hir M; Kaissling B; Ambühl PM
    J Am Soc Nephrol; 2002 Sep; 13(9):2199-206. PubMed ID: 12191963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.